Utility of repeat latent tuberculosis testing with the Quanti FERON ‐ TB Gold test in patients with psoriasis treated with tumour necrosis factor‐α inhibitors at a single U.S. institution-Reference-Cited by-同舟云学术

Utility of repeat latent tuberculosis testing with the Quanti FERON ‐ TB Gold test in patients with psoriasis treated with tumour necrosis factor‐α inhibitors at a single U.S. institution

Published:2019-11-06 Issue:3 Volume:182 Page:800-802
ISSN:0007-0963
Container-title:British Journal of Dermatology
language:en
Short-container-title:Br J Dermatol

Author:

Ya J.¹,Khanna U.²^ORCID,Havele S.³,Fernandez A.P.²⁴^ORCID

Affiliation:

1. Cleveland Clinic Lerner College of Medicine of Case Western Reserve University Cleveland OH U.S.A.

2. Department of DermatologyCleveland Clinic Cleveland OH U.S.A.

3. Department of Pathology Cleveland Clinic Cleveland OH U.S.A.

4. Case Western Reserve University School of Medicine Cleveland OH U.S.A.

Publisher

Wiley

Subject

Dermatology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/bjd.18461

Reference8 articles.

1. Risk of tuberculosis in patients treated with TNF-α antagonists: a systematic review and meta-analysis of randomised controlled trials

2. National Psoriasis Foundation consensus statement on screening for latent tuberculosis infection in patients with psoriasis treated with systemic and biologic agents

3. Centers for Medicare and Medicaid Services.Psoriasis: Tuberculosis (TB) prevention for patients with psoriasis psoriatic arthritis and rheumatoid arthritis patients on a biological immune response modifier. Available at:https://qpp.cms.gov/docs/QPP_quality_measure_specifications/CQM-Measures/2019_Measure_337_MIPSCQM.pdf(last accessed 2 October 2019).

4. Managing Patients With Psoriasis in the Busy Clinic

5. Serial QuantiFERON-TB Gold In-Tube testing for psoriatic patients receiving antitumor necrosis factor-alpha therapy

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Low rate of seroconversion analyzing QuantiFERON TB-gold testing in patients with psoriasis and hidradenitis suppurativa taking biologic therapy at an academic center in New York City;JAAD International;2024-09

2. Tuberculosis screening for patients on biologic Medications: A Single-Center experience and Society guideline Review, Monroe County, New York, 2018–2021;Journal of Clinical Tuberculosis and Other Mycobacterial Diseases;2024-08

3. Dermatology practice updates in mycobacterial disease;International Journal of Dermatology;2023-12-14

4. Safety of current systemic therapies for nail psoriasis;Expert Opinion on Drug Safety;2023-05-04

5. Routine rescreening for latent tuberculosis has low utility in patients with chronic immune-mediated inflammatory diseases treated with biologics: A single-center, retrospective cohort study;Journal of the American Academy of Dermatology;2022-10